CVAC – CureVac N.V.

Float Short %

1.73

Margin Of Safety %

Put/Call OI Ratio

0.54

EPS Next Q Diff

EPS Last/This Y

-1.38

EPS This/Next Y

0.04

Price

5.07

Target Price

5.45

Analyst Recom

Performance Q

-5.78

Relative Volume

0.75

Beta

1.83

Ticker: CVAC

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	CVAC	5.32	0.08	0.00	1518
2025-11-14	CVAC	5.29	0.08	0.00	1520
2025-11-17	CVAC	5.28	0.08	0.00	1520
2025-11-18	CVAC	5.23	0.08	0.50	1521
2025-11-19	CVAC	5.24	0.08	0.15	1523
2025-11-20	CVAC	5.14	0.08	0.07	1562
2025-11-21	CVAC	5.03	0.08	0.07	1562
2025-11-24	CVAC	5.12	0.06	2.71	1497
2025-11-25	CVAC	5.29	0.07	11.00	1519
2025-11-26	CVAC	5.48	0.08	0.02	1528
2025-12-01	CVAC	5.23	0.09	999.99	1577
2025-12-02	CVAC	5.12	0.17	1.41	1699
2025-12-03	CVAC	5.18	0.26	999.99	1974
2025-12-04	CVAC	5.12	0.48	999.99	2316
2025-12-05	CVAC	5.13	0.48	2.07	2317
2025-12-08	CVAC	5.22	0.50	1.00	2362
2025-12-09	CVAC	5.14	0.50	12.00	2363
2025-12-10	CVAC	5.12	0.50	4.00	2365
2025-12-11	CVAC	5.13	0.54	2.65	2457
2025-12-12	CVAC	5.07	0.54	5.17	2485
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	CVAC	5.32	-104.7	-330.8	-0.54
2025-11-14	CVAC	5.29	-104.7	-331.3	-0.54
2025-11-17	CVAC	5.28	-104.7	-331.8	-0.54
2025-11-18	CVAC	5.23	-104.7	-330.5	-0.54
2025-11-19	CVAC	5.22	-104.7	-331.4	-0.54
2025-11-20	CVAC	5.14	-104.7	-329.5	-0.54
2025-11-21	CVAC	5.03	-104.7	-329.0	-0.54
2025-11-24	CVAC	5.11	-104.7	-333.4	-0.54
2025-11-25	CVAC	5.28	-104.7	-335.2	-0.54
2025-11-26	CVAC	5.49	-104.7	-269.8	-0.54
2025-12-01	CVAC	5.20	35.7	-258.8	-0.54
2025-12-02	CVAC	5.11	35.7	-263.1	-0.54
2025-12-03	CVAC	5.16	35.7	-266.4	-0.54
2025-12-04	CVAC	5.12	35.7	-266.5	-0.54
2025-12-05	CVAC	5.12	35.7	-267.5	-0.54
2025-12-08	CVAC	5.21	35.7	-	-0.54
2025-12-09	CVAC	5.12	35.7	-265.1	-0.54
2025-12-10	CVAC	5.12	35.7	-267.3	-0.54
2025-12-11	CVAC	5.13	35.7	-267.6	-0.54
2025-12-12	CVAC	5.07	35.7	-266.3	-0.54
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	CVAC	0.00	2.09	0.84
2025-11-14	CVAC	0.00	2.09	0.84
2025-11-17	CVAC	0.00	1.23	0.84
2025-11-18	CVAC	0.00	1.23	0.84
2025-11-19	CVAC	0.00	1.23	0.84
2025-11-20	CVAC	0.00	1.23	0.84
2025-11-21	CVAC	0.00	1.23	0.84
2025-11-24	CVAC	0.00	4.71	0.84
2025-11-25	CVAC	0.00	4.71	0.84
2025-11-26	CVAC	0.00	4.71	1.00
2025-12-01	CVAC	0.00	4.73	1.00
2025-12-02	CVAC	0.00	4.73	1.00
2025-12-03	CVAC	0.00	4.73	1.00
2025-12-04	CVAC	0.00	4.73	1.00
2025-12-05	CVAC	0.00	4.73	1.00
2025-12-08	CVAC	0.00	4.72	1.00
2025-12-09	CVAC	0.00	4.72	1.00
2025-12-10	CVAC	0.00	4.72	1.73
2025-12-11	CVAC	0.00	4.72	1.73
2025-12-12	CVAC	0.00	4.72	1.73
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="CVAC" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.1

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

4.72

Beta

1.83

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

96.2

Max Drawdown 5-Year %

-98.2

Target Price

5.45

P/E

7.07

Forward P/E

PEG

P/S

14.03

P/B

1.11

P/Free Cash Flow

EPS

0.71

Average EPS Est. Cur. Y

-0.54

EPS Next Y. (Est.)

-0.5

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

199.84

Relative Volume

0.75

Return on Equity vs Sector %

-12.1

Return on Equity vs Industry %

2.9

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.11

EBIT Estimation

-266.3

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”CVAC” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CVAC” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CVAC” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CVAC” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CVAC” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CVAC” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CVAC” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

CureVac N.V.

Sector: Healthcare

Industry: Biotechnology

Employees: 825

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company's portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology and instructs human cells to produce or secrete specific proteins in the nucleus, cytoplasm, cellular organelles, and cell membrane. In addition, the company offers The RNA Printer, a downsized, integrated, and highly automated process for manufacturing of mRNA vaccines and therapeutics. Further, it develops prophylactic vaccine lead candidate that addresses urinary tract infections targeting uropathogenic E. coli (UPEC) bacteria; vaccine candidates CV0601 and CV0701, which are in phase 2 clinical study against SARS-CoV-2; vaccines for off-the-shelf and fully personalized cancer precision immunotherapies in oncology; and CVGBM for treating cancer. Additionally, the company develops, manufactures, and commercializes mRNA vaccines targeting SARS-CoV-2 variants; antigen cancer precision immunotherapy candidate that targets squamous non-small cell lung cancer; and antigen cancer precision immunotherapy candidate CVGBM that is tested in patients with surgically resected MGMT-unmethylated glioblastoma or astrocytoma with a molecular signature of glioblastoma. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

stock quote shares CVAC – CureVac N.V. Stock Price stock today

news today CVAC – CureVac N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch CVAC – CureVac N.V. yahoo finance google finance

stock history CVAC – CureVac N.V. invest stock market

stock prices CVAC premarket after hours

ticker CVAC fair value insiders trading

CVAC – CureVac N.V.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CVAC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y